KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Payables (2016 - 2025)

Xylem has reported Payables over the past 16 years, most recently at $1.0 billion for Q4 2025.

  • Quarterly results put Payables at $1.0 billion for Q4 2025, up 0.7% from a year ago — trailing twelve months through Dec 2025 was $1.0 billion (up 0.7% YoY), and the annual figure for FY2025 was $1.0 billion, up 0.7%.
  • Payables for Q4 2025 was $1.0 billion at Xylem, up from $968.0 million in the prior quarter.
  • Over the last five years, Payables for XYL hit a ceiling of $1.0 billion in Q2 2025 and a floor of $530.0 million in Q1 2021.
  • Median Payables over the past 5 years was $935.0 million (2024), compared with a mean of $819.2 million.
  • Biggest five-year swings in Payables: surged 52.59% in 2023 and later dropped 2.89% in 2024.
  • Xylem's Payables stood at $639.0 million in 2021, then grew by 13.15% to $723.0 million in 2022, then soared by 33.89% to $968.0 million in 2023, then increased by 3.93% to $1.0 billion in 2024, then increased by 0.7% to $1.0 billion in 2025.
  • The last three reported values for Payables were $1.0 billion (Q4 2025), $968.0 million (Q3 2025), and $1.0 billion (Q2 2025) per Business Quant data.